Get the Stockscreener App
15.27
19.48%
2.49
After Hours:
10.36
-4.91
-32.15%
Bioaffinity Technologies Inc stock is traded at $15.27, with a volume of 19.37M.
It is up +19.48% in the last 24 hours and up +2,674% over the past month.
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
See More
Previous Close:
$12.78
Open:
$11.12
24h Volume:
19.37M
Relative Volume:
3.89
Market Cap:
$123.71M
Revenue:
$5.66M
Net Income/Loss:
$-15.88M
P/E Ratio:
-1.3497
EPS:
-11.3134
Net Cash Flow:
$-10.93M
1W Performance:
+213.55%
1M Performance:
+2,674%
6M Performance:
+1,383%
1Y Performance:
+112.79%
1-Day Range:
$10.90
$20.35
1-Week Range:
$4.56
$20.35
52-Week Range:
$0.3252
$20.35
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, NTRA, IQV, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
15.27 | 3.24M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat
Trending Stocks Today | BioAffinity Technologies Shoots up 56.75% - Moomoo
Small Cap Stocks To Follow NowSeptember 5th - MarketBeat
BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - stockstotrade.com
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance
AOUT, NX, and BIAF stocks soar on strong earnin... - Pluang
bioAffinity Technologies Inc. Warrant (BIAFW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$15.5 to $19.35 🫡 - Moomoo
You know I'm drunk, so my words carry extra weight 😘 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
bioAffinity Technologies to Present Corporate Update at Conference - TipRanks
bioAffinity Technologies to Present Corporate Update at H.C. Wainwright Conference; Market Cap ~$5.9M - TradingView
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federa - The National Law Review
Biotech Stocks To Follow NowSeptember 3rd - MarketBeat
BIAF Stock Pops As Federal Lung Test Deal Fuels Momentum - timothysykes.com
BIAF Stock Jumps As Federal Deal Fuels Lung Test Growth - StocksToTrade
bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BIAF Stock Pops As CyPath Lung Scores Big VA Deal - timothysykes.com
Why is bioAffinity Technologies stock surging today? By Investing.com - Investing.com Nigeria
Small Cap Stocks To Watch NowSeptember 2nd - MarketBeat
bioAffinity Technologies Surges as CyPath Lung Expands Into Cancer Recurrence Monitoring - finance.biggo.com
BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening? - Benzinga
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors - BioSpace
Get insights into the top gainers and losers of Tuesday's after-hours session. - ChartMill
bioAffinity Technologies advances CyPath Lung for post-treatment surveillance - TradingView
Why Is bioAffinity Technologies Stock Trading Higher Today?bioAffinity Technologies (NASDAQ:BIAF) - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Top Biotech Stocks Worth WatchingSeptember 1st - MarketBeat
bioAffinity Technologies Advances CyPath Lung for Post-Treatment Lung Cancer Surveillance - Yahoo Finance
BIAF jumps as bioAffinity highlights expanded CyPath Lung use case - Quiver Quantitative
bioAffinity shares jump 45% on CyPath news, trading volume rises to 56 times share count - TechStock²
BIAF Stock Surges On VA Deal And Lung Test Momentum - stockstotrade.com
BIAF Stock Pops As Federal Deal Fuels Volatile Run - timothysykes.com
$bioAffinity Technologies (BIAF.US)$ sold a tad early.. but managed to kept my greens! - Moomoo
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
bioAffinity (BIAF) Results Review: The EPS Result Is Below Expectation for This Review; Closing Reaction: The Market Price Declines 1.25% at the CloseEstimate Revision Count - vinanet.vn
bioAffinity Technologies Inc. Warrant (BIAFW) Peer Comparison – Compare with Others - valueresearchonline.com
Price to earnings forward of bioAffinity Technologies, Inc. – BOATS:BIAFW - TradingView
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - BioSpace
bioAffinity Technologies Implements Reverse Stock Split for Nasdaq - TipRanks
bioAffinity Technologies Sets 1-for-15 Reverse Stock Split for August 24 - citybiz
bioAffinity Technologies executes 1-for-15 reverse stock split - Investing.com
BioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - marketscreener.com
bioAffinity (BIAF) Earnings Snapshot: The Available Earnings Metric Delivers a Miss in the Reported Period; Trading Move: The Stock Ends Down 13.59% in Latest TradingFinancial Summary - vinanet.vn
BioAffinity Technologies Announces Closing of - Moomoo
bioAffinity Technologies expands CyPath Lung federal distribution - The Globe and Mail
These stocks are the most active in today's session - ChartMill
bioAffinity Technologies Signs Nationwide Federal Healthcare Distribution Agreement for CyPath Lung - Yahoo Finance
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):